CA2319542A1 - The treatment of sexual dysfunction in certain patient groups - Google Patents

The treatment of sexual dysfunction in certain patient groups Download PDF

Info

Publication number
CA2319542A1
CA2319542A1 CA002319542A CA2319542A CA2319542A1 CA 2319542 A1 CA2319542 A1 CA 2319542A1 CA 002319542 A CA002319542 A CA 002319542A CA 2319542 A CA2319542 A CA 2319542A CA 2319542 A1 CA2319542 A1 CA 2319542A1
Authority
CA
Canada
Prior art keywords
sexual dysfunction
patient groups
treatment
certain patient
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002319542A
Other languages
French (fr)
Other versions
CA2319542C (en
Inventor
Neal R. Cutler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RT ALAMO VENTURES Inc
Original Assignee
Rt Alamo Ventures, Inc.
Neal R. Cutler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/071,457 external-priority patent/US6110489A/en
Priority claimed from US09/166,703 external-priority patent/US6194433B1/en
Priority claimed from US09/175,395 external-priority patent/US6132753A/en
Priority claimed from US09/260,099 external-priority patent/US6132757A/en
Priority claimed from US09/262,715 external-priority patent/US6187790B1/en
Application filed by Rt Alamo Ventures, Inc., Neal R. Cutler filed Critical Rt Alamo Ventures, Inc.
Publication of CA2319542A1 publication Critical patent/CA2319542A1/en
Application granted granted Critical
Publication of CA2319542C publication Critical patent/CA2319542C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

Methods for treating specific patient groups for sexual dysfunction are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions in patients who are free of cardiac disease and/or who have not been given organic nitrates.
CA002319542A 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups Expired - Fee Related CA2319542C (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US09/071,457 US6110489A (en) 1998-05-01 1998-05-01 Use of quinolines and quinolones to treat male erectile dysfunction
US09/166,703 US6194433B1 (en) 1998-10-05 1998-10-05 Sexual dysfunction in females
US09/175,395 US6132753A (en) 1998-05-01 1998-10-19 Treatment of sexual dysfunction in certain patient groups
US09/260,099 US6132757A (en) 1998-05-01 1999-03-02 Treatment of sexual dysfunction in certain patient groups
US09/175,395 1999-03-04
US09/262,715 US6187790B1 (en) 1999-03-04 1999-03-04 Use of cilostazol for treatment of sexual dysfunction
US09/071,457 1999-03-04
US09/262,715 1999-03-04
US09/166,703 1999-03-04
US09/260,099 1999-03-04
PCT/US1999/009610 WO1999056666A1 (en) 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups

Publications (2)

Publication Number Publication Date
CA2319542A1 true CA2319542A1 (en) 1999-11-11
CA2319542C CA2319542C (en) 2005-07-12

Family

ID=27535884

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002319542A Expired - Fee Related CA2319542C (en) 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups

Country Status (7)

Country Link
EP (1) EP1079764A4 (en)
JP (1) JP2002537231A (en)
AU (1) AU3780699A (en)
BR (1) BR9908716A (en)
CA (1) CA2319542C (en)
MX (1) MXPA00010254A (en)
WO (1) WO1999056666A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6541487B1 (en) * 1998-05-01 2003-04-01 R.T. Alamo Ventures I, Llc PDE III inhibitors for treating sexual dysfunction
WO2002058703A2 (en) * 2001-01-26 2002-08-01 R.T. Alamo Ventures I, Llc The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
US6730790B2 (en) 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis
US6767914B2 (en) 2002-03-01 2004-07-27 R.T. Alamo Ventures I, Llc Fluorinated heterocyclic compounds and methods of synthesis
US6727262B2 (en) 2002-03-01 2004-04-27 R.T. Alamo Ventures I, Llc Dichlorinated heterocyclic compounds and methods of synthesis
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
DE4117249C2 (en) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomine used to treat erectile dysfunction
EP0651640A1 (en) * 1992-07-21 1995-05-10 Knoll AG Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
AU5509099A (en) * 1998-08-03 2000-02-28 Basf Corporation Pyridinones for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
CA2319542C (en) 2005-07-12
AU3780699A (en) 1999-11-23
WO1999056666A1 (en) 1999-11-11
MXPA00010254A (en) 2002-08-06
EP1079764A4 (en) 2001-09-12
EP1079764A1 (en) 2001-03-07
JP2002537231A (en) 2002-11-05
BR9908716A (en) 2000-11-21
WO1999056666A8 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
WO2004019884A3 (en) Agents and methods for enhancing bone formation
CA2184916A1 (en) Use of fibroblast growth factors to stimulate bone growth
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
CA2294921A1 (en) Levobupivacaine and its use
BR9813318A (en) Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient
DE69521536T2 (en) Compositions containing G-CSF and a TNF binding protein
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
HUP0302538A3 (en) 3,7-diazabicyclo[3.3.0]oczanes and their use in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
DE69939075D1 (en) Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus
EP0744176A3 (en) Methods for inhibiting bone loss
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
EP0821969A3 (en) Medicinal Composition comprising TCF-II
CA2290739A1 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
MA26648A1 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION.
WO2000078800A3 (en) Combined decorin binding protein and outer surface protein compositions and methods of use
CA2097878A1 (en) Therapeutic agent for neutropenia
CA2309653A1 (en) Use of protein h as cytostatic agent
UA32241A (en) Method for treating inflammations in experiment
AU2002300509A1 (en) The Treatment of Sexual Dysfunction in Certain Patient Groups
RU93014293A (en) METHOD OF TREATMENT OF CHRONIC BRONCHITIS

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed